Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BMX-001 acts as a selective chemoradioprotector in rectal cancer.

Redox biochemistry and chemistry·2026
Same author

Polyketide synthase-like functionality acquired by plant fatty acid elongase.

Science advances·2026
Same author

Understanding Rice Responses to the Combination of Bacterial Panicle Blight and High Night Temperatures.

Rice (New York, N.Y.)·2026
Same author

Commentary on the Dietary Guidelines for Americans 2026-2030.

Nutrition reviews·2026
Same author

Social Health Programming During Adolescence Is Associated with Increased Serum Levels of Carotenoids, Vitamin A, and Vitamin E in Young Women: An Observational Cohort Study.

Antioxidants (Basel, Switzerland)·2026
Same author

Asthma in pregnancy: contemporary management.

American journal of obstetrics and gynecology·2026

Related Experiment Video

Updated: May 23, 2025

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.1K

Diet-Microbiome Interactions Influence Lung Function in Chronic Obstructive Pulmonary Disease.

Haowen Qiu1, Rees Checketts2, Mariah Kay Jackson3

  • 1Bioinformatics Core Research Facility, Nebraska Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, USA.

Frontiers in Microbiomes
|May 22, 2025
PubMed
Summary

Diet and gut microbiome composition influence lung function in Chronic Obstructive Pulmonary Disease (COPD). This study explored how gut bacteria correlate with COPD severity and mediate diet-lung function relationships.

Keywords:
COPDDietFiberLungsMicrobiomeOmega-3 Fatty Acid

More Related Videos

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on: August 3, 2021

2.3K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.7K

Related Experiment Videos

Last Updated: May 23, 2025

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.1K
Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on: August 3, 2021

2.3K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.7K

Area of Science:

  • Pulmonary Medicine
  • Microbiome Research
  • Nutritional Science

Background:

  • Diet impacts pulmonary function and gut microbiome composition.
  • The gut-lung axis links gut health to respiratory conditions.
  • Limited understanding exists on how the gut microbiome mediates diet's effect on COPD progression.

Purpose of the Study:

  • To investigate correlations between gastrointestinal microbiota and COPD severity.
  • To determine if the gut microbiome mediates the relationship between diet and lung function in COPD patients.
  • To explore the influence of specific dietary components like fiber and omega-3 fatty acids.

Main Methods:

  • Analysis of gut microbiota composition in COPD patients across different disease stages.
  • Correlation of microbial taxa with spirometry measures and disease severity.
  • Assessment of the mediating role of the microbiome in diet-lung function relationships.

Main Results:

  • Taxonomic differences in gut microbiome were observed across COPD stages.
  • Specific microbial patterns were associated with respiratory disease severity.
  • Evidence suggests the gut microbiome mediates the impact of diet on pulmonary function in COPD.

Conclusions:

  • Gut microbiome composition varies with COPD severity.
  • Diet-microbiome interactions play a significant role in COPD pathogenesis and progression.
  • Targeting the gut microbiome may offer novel therapeutic strategies for COPD management.